Asia Pacific Heart Valve Devices Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
USD 4,547.53 million |
 Market Size (Forecast Year) |
USD 4,547.53 million |
 CAGR |
% |
| Major Markets Players |
亚太心脏瓣膜设备市场，按产品类型（机械心脏瓣膜、生物心脏瓣膜和经导管瓣膜）、治疗（开放手术和微创手术 (MIS)）、最终用户（医院和诊所、门诊手术中心、心脏中心、研究中心等）、分销渠道（直接招标、第三方分销商）划分的行业趋势及预测至 2030 年。
亚太心脏瓣膜设备市场分析与洞察
心脏瓣膜装置用于治疗阻塞的心脏瓣膜，植入这些装置是最常见的手术之一。市场上的结构性心脏瓣膜装置包括机械瓣膜、生物瓣膜和经导管瓣膜。由于全球心脏瓣膜手术数量的增加，亚太地区心脏瓣膜装置市场在预测期内可能会稳步增长。预计亚太地区心脏瓣膜装置市场的增长将受到结构性心脏装置和手术（如主动脉瓣、左心房封堵装置和组织或生物瓣膜）发展的推动。组织瓣膜已经彻底改变了心脏瓣膜装置市场。下一代心脏瓣膜手术提供低分娩患者概况、更可控的手术、更好的瓣膜功能、减少瓣周反流、提高耐用性和降低成本。主要市场参与者的产品创新促进了市场的增长，使他们能够满足更大的患者群体并取得更好的临床结果。
Data Bridge Market Research 分析称，预计到 2030 年，亚太心脏瓣膜设备市场价值将达到 45.4753 亿美元，预测期内复合年增长率为 14.5%。由于全球对心脏瓣膜设备的需求迅速增长，产品类型占据了市场中最大的类型细分市场。本市场报告还深入介绍了定价分析、专利分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2020 - 2015） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按产品类型（机械心脏瓣膜、生物心脏瓣膜和经导管瓣膜）、治疗（开放手术和微创手术 (MIS)）、最终用户（医院和诊所、门诊手术中心、心脏中心、研究中心和其他）、分销渠道（直接招标、第三方分销商）。 |
|
覆盖国家 |
中国、日本、印度、澳大利亚、新西兰、韩国、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、越南、台湾和亚太其他地区 |
|
涵盖的市场参与者 |
雅培 (Abbott)、波士顿科学公司 (Boston Scientific Corporation) 或其附属公司、Artivion, Inc.、Edwards Lifesciences Corporation、美敦力 (Medtronic)、NeoVasc、Micro Interventional Devices Incorporated、XELTIS、TTK、Meril Life Sciences Pvt. Ltd、Foldax, Inc.、启明医疗 (杭州) 股份有限公司 (Venus Medtech (Hangzhou) Inc.)、Colibri Heart Valve 等等。 |
心脏瓣膜设备市场定义
心脏瓣膜对于确保血液在体内以正确的方向平稳流动是必不可少的。心脏瓣膜负责血液的持续流动和维持血压。如果它们不能正常工作，切断心脏会导致狭窄。心脏病通常包括几种严重影响心脏的疾病。随着心血管疾病患者数量的增加，心脏瓣膜的调节在过去十年中迅速增加。不稳定的生活方式、生活方式疾病、吸烟人口增加、人口老龄化、医疗保健质量的提高以及预测期内医疗保健报销的快速发展等因素加速了心脏瓣膜市场的增长。此外，心脏瓣膜的高成本和心脏植入物的感染风险可能是在上述预测期内可能减缓心脏瓣膜市场增长的原因。新兴经济体医疗业务方面的增长和基础工作正在推动医疗旅游业的增长，推动心脏瓣膜设备市场的发展。对治疗心脏异常的微创手术的需求大大增加。目前心脏瓣膜手术中自动化的应用，例如经导管主动脉瓣置换术 (TAVR)，已经让位于越来越多类似的手术。从老龄化人口比例的增加来看，人寿保险单的增加也有望促进心脏瓣膜市场的增长。
心脏瓣膜设备市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
- 心脏瓣膜装置的创新可改善临床疗效
推出用于微创手术的新产品可能会推动亚太心脏瓣膜设备市场的发展。组织瓣膜彻底改变了心脏瓣膜市场。下一代心脏瓣膜手术提供更少的输送曲线、更可控的放置、更好的瓣膜功能、更少的瓣膜反流、更高的耐用性和更低的成本。产品创新提升了心脏瓣膜设备市场参与者的增长前景，因为它可以治疗更多患者并获得更好的临床结果。尽管近年来取得了重大进展，但结构性介入心脏病学仍然是一个具有巨大潜力的新兴市场。
此外，智能设计、新技术和生物材料应用不断推动新产品开发的边界，确保这些设备在未来几年内处于介入产品创新的前沿。设计创新正在帮助市场参与者挖掘心脏瓣膜设备的盈利增长机会。
因此，随着心脏瓣膜设备创新的不断增加，亚太地区心脏瓣膜设备市场的增长预计将得到推动。
- 各种心脏病发病率上升
心脏病发作和中风通常是急性事件，主要由阻塞导致血液流向心脏或大脑引起。在 COVID-19 大流行的第一年，心脏病和中风死亡人数分别增加了 5.8% 和 6.8%。然而，与年龄相关的心脏病和中风死亡人数分别增加了 1.6% 和 1.7%。最常见的原因是供应心脏或大脑的血管内壁脂肪沉积。中风可能是由脑血管出血或血栓引起的。这一趋势表明，由于人口增长和老龄化，心血管疾病的发病率可能会急剧上升。
此外，高糖尿病和 高血压、高胆固醇和吸烟是心脏病的主要危险因素。美国约有一半的人（47%）至少有这三种风险因素中的一种。其他医疗状况和生活方式选择也会使人们面临更高的心脏病风险，包括不健康的饮食、缺乏运动和过量饮酒。
此外，心脏病发病率的上升预计将成为亚太地区心脏瓣膜装置市场发展的推动力。
机会
- 提高对假肢的认识
假体是一种用于替换缺失的身体部位或改善身体部位功能的装置。在需要干预的天然瓣膜异常情况下，人工心脏瓣膜的使用越来越多。一般来说，它们可以分为机械心脏瓣膜、生物瓣膜和同种异体移植物。人工瓣膜的目标是在血液动力学上像天然瓣膜一样起作用，同时将副作用降至最低。心血管假体装置已被开发用于替换受损的心脏组织。这些医疗设备旨在模仿正常心血管器官的功能。人工心脏使心脏外科医生能够增加对心脏传导阻滞的治疗。
此外，人工瓣膜的患病率为 1,000 岁以上人群中每 1,000 人中有 0.2 人，而 2,000 岁以下人群中每 1,000 人中有 5.3 人。
因此，人们对假肢认识的不断提高为市场的增长提供了机会。
克制/挑战
- 设备生产成本昂贵
在美国，接受主动脉瓣疾病治疗的患者数量正在快速增长。经导管主动脉瓣置换术 (TAVR) 取代了外科主动脉瓣置换术 (SAVR) 和药物治疗 (MT)。这些趋势的经济后果尚不清楚。因此，TAVR 的总成本高于 SAVR，并且比单独的 MT 昂贵得多。TAVR 成本随着时间的推移而下降，而 SAVR 和 MT 成本保持不变。
- 此外，TAVI手术费用高主要是因为制作成本高，但由于住院时间较短，非手术TAVI费用比AVR低。单单TAVI植入套件（瓣膜、球囊、鞘管）的费用就高达32500美元，而手术瓣膜仅需5000美元左右，就如在瑞士，TAVI植入套件费用约为32000法郎（约合35000美元），而生物手术假体费用约为3000瑞士法郎（约合3300美元）。根据合并症和并发症不同，美国的报销金额在0,000美元到5,000美元之间，瑞士的TAVI约为72,000法郎（78,000美元），AVR约为3,000法郎（7,000美元），这对于医院来说意味着经济损失。
因此，设备生产成本的上升可能会阻碍市场的增长。
最新动态
- 2023 年 9 月，雅培发布了五项后期演示的数据，展示了其微创设备在治疗各种结构性心脏病患者方面的优势。这些数据包括支持 MitraClip™ 价值的发现。它是世界上第一个也是领先的经导管边缘到边缘修复 (TEER)，用于治疗二尖瓣反流 (MR) 患者的漏瓣。在波士顿举行的心血管研究基金会第 34 届年度经导管心血管治疗 (TCT) 科学研讨会上，雅培结构性心脏疗法的新数据被公布。这有助于该公司提高其在市场上的业务地位。
- 2020年9月，波士顿科学公司宣布在欧洲引入ACURATE neo2™主动脉瓣系统。该新一代经导管主动脉瓣植入（TAVI）技术是一个新平台，具有多项功能设计，可提高原有ACURATE新平台的临床性能。与上一代相比，ACURATE neo2瓣膜系统扩大了主动脉瓣狭窄患者的适应症。这有助于该公司获得其产品组合。
心脏瓣膜设备市场范围
心脏瓣膜设备市场细分为产品类型、治疗、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
按产品类型
- 机械心脏瓣膜
- 生物心脏瓣膜
- 经导管瓣膜
根据产品类型，心脏瓣膜装置市场分为机械心脏瓣膜、生物心脏瓣膜和经导管瓣膜。
治疗方式
- 开放手术
- 微创手术
根据治疗方法，心脏瓣膜装置市场分为开放手术和微创手术。
由最终用户
- 医院和诊所
- 门诊手术中心
- 心脏中心
- 研究中心
- 其他的
根据最终用户，心脏瓣膜装置市场分为医院和诊所、门诊手术中心、心脏中心、研究中心和其他。
按分销渠道
- 直接招标
- 第三方分销商
根据分销渠道，心脏瓣膜设备市场分为直接招标和第三方分销商
亚太心脏瓣膜设备市场区域分析/见解
对心脏瓣膜装置市场进行分析，并提供市场规模信息，包括产品类型、治疗方法、最终用户和分销渠道。
本市场报告涵盖的国家包括中国、日本、印度、澳大利亚、新西兰、韩国、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、越南、台湾和亚太地区其他地区。
由于心脏瓣膜疾病相关手术设备的供应增加，中国在亚太地区占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，以及销售渠道的影响。
竞争格局和心脏瓣膜设备市场份额分析
心脏瓣膜设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和宽度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对心脏瓣膜设备市场的关注有关。
心脏瓣膜设备市场的一些主要参与者包括雅培、波士顿科学公司或其附属公司、Artivion, Inc.、爱德华生命科学公司、美敦力、NeoVasc、Micro Interventional Devices Incorporated、XELTIS、TTK、Meril Life Sciences Pvt. Ltd、Foldax, Inc.、启明医疗（杭州）有限公司、Colibri Heart Valve 等。
研究方法：心脏瓣膜设备市场
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、亚太地区与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC HEART VALVE DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 EPIDEMIOLOGY
3.2 PESTEL ANALYSIS
3.3 PORTER'S FIVE FORCE
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 INNOVATIONS IN HEART VALVE DEVICES OFFER IMPROVED CLINICAL OUTCOME
4.1.2 RISING NUMBER OF VARIOUS HEART DISEASES
4.1.3 ADVANCEMENTS IN TRANSCATHETER VALVE TECHNOLOGY
4.1.4 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
4.2 RESTRAINTS
4.2.1 HIGH COST ASSOCIATED WITH THE SURGERIES
4.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT
4.3 OPPORTUNITIES
4.3.1 INCREASING AWARENESS OF PROSTHETIC DEVICES
4.3.2 RISING PREVALENCE OF STROKE & CARDIAC ARREST TO REINFORCE DEMAND FOR HEART VALVE DEVICES
4.3.3 INCREASING FDA APPROVALS OF TRANSCATHETER AORTIC VALVES
4.4 CHALLENGES
4.4.1 STRICT GOVERNMENT REGULATIONS
4.4.2 EXPENSIVE PRODUCTION COST OF EQUIPMENT
5 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 MECHANICAL HEART VALVES
5.2.1 AORTIC VALVE
5.2.2 MITRAL VALVE
5.3 BIOLOGICAL HEART VALVES
5.3.1 AORTIC VALVE
5.3.2 MITRAL VALVE
5.3.3 PULMONARY VALVE
5.3.4 TRICUSPID VALVE
5.4 TRANSCATHETER VALVE
5.4.1 AORTIC VALVE
5.4.2 MITRAL VALVE
5.4.3 PULMONARY VALVE
6 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY TREATMENT
6.1 OVERVIEW
6.2 MINIMALLY INVASIVE SURGERY (MIS)
6.2.1 CARDIAC VALVE REPLACEMENT
6.2.2 CARDIAC VALVE REPAIR
6.3 OPEN SURGERY
6.3.1 CARDIAC VALVE REPLACEMENT
6.3.2 CARDIAC VALVE REPAIR
7 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL & CLINICS
7.3 AMBULATORY SURGICAL CENTERS
7.4 CARDIAC CENTERS
7.5 RESEARCH CENTERS
7.6 OTHERS
8 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDER
8.3 THIRD PARTY DISTRIBUTORS
9 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY REGION
9.1 ASIA-PACIFIC
9.1.1 CHINA
9.1.2 JAPAN
9.1.3 SOUTH KOREA
9.1.4 INDIA
9.1.5 AUSTRALIA
9.1.6 SINGAPORE
9.1.7 TAIWAN
9.1.8 THAILAND
9.1.9 MALAYSIA
9.1.10 INDONESIA
9.1.11 PHILIPPINES
9.1.12 NEW ZEALAND
9.1.13 VIETNAM
9.1.14 REST OF ASIA-PACIFIC
10 ASIA PACIFIC HEART VALVE DEVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 EDWARDS LIFESCIENCES CORPORATION
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 ARTIVION, INC.
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 COLIBRI HEART VALVE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 FOLDAX, INC.
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 MERIL LIFE SCIENCES PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 MICRO INTERVENTIONAL DEVICES, INCORPORATED.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 NEOVASC
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 TTK
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 VENUS MEDTECH (HANGZHOU) INC.
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 XELTIS
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
表格列表
TABLE 1 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 ASIA PACIFIC MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 ASIA PACIFIC MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 ASIA PACIFIC BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 ASIA PACIFIC BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 ASIA PACIFIC TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 ASIA PACIFIC TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 9 ASIA PACIFIC MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 ASIA PACIFIC MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC HOSPITALS & CLINICS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC CARDIAC CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC RESEARCH CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC OTHERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC DIRECT TENDER IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 23 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA-PACIFIC MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 ASIA-PACIFIC BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 ASIA-PACIFIC TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 32 CHINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 33 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 35 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 36 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 38 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 39 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 41 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 42 CHINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 43 CHINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 44 CHINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 45 CHINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 CHINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 47 JAPAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 50 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 51 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 52 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 53 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 54 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 56 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 57 JAPAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 58 JAPAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 59 JAPAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 60 JAPAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 JAPAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 SOUTH KOREA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 65 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 66 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 68 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 69 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 70 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 71 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 72 SOUTH KOREA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 73 SOUTH KOREA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 74 SOUTH KOREA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 75 SOUTH KOREA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 SOUTH KOREA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 77 INDIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 78 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 80 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 81 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 83 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 84 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 86 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 87 INDIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 88 INDIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 89 INDIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 90 INDIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 INDIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 AUSTRALIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 94 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 95 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 96 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 98 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 99 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 101 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 102 AUSTRALIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 103 AUSTRALIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 104 AUSTRALIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 105 AUSTRALIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 106 AUSTRALIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 107 SINGAPORE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 109 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 110 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 111 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 113 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 114 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 116 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 117 SINGAPORE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 118 SINGAPORE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 119 SINGAPORE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 120 SINGAPORE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 SINGAPORE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 122 TAIWAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 125 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 126 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 128 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 129 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 131 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 132 TAIWAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 133 TAIWAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 134 TAIWAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 135 TAIWAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 136 TAIWAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 137 THAILAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 140 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 141 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 143 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 144 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 146 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 147 THAILAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 148 THAILAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 149 THAILAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 150 THAILAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 THAILAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 152 MALAYSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 154 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 155 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 156 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 157 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 158 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 159 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 161 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 162 MALAYSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 163 MALAYSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 164 MALAYSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 165 MALAYSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 166 MALAYSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 167 INDONESIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 168 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 169 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 170 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 171 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 173 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 174 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 176 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 177 INDONESIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 178 INDONESIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 179 INDONESIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 180 INDONESIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 181 INDONESIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 182 PHILIPPINES HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 185 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 186 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 188 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 189 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 191 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 192 PHILIPPINES HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 193 PHILIPPINES MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 194 PHILIPPINES OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 195 PHILIPPINES HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 196 PHILIPPINES HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 197 NEW ZEALAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 200 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 201 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 203 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 204 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 206 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 207 NEW ZEALAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 208 NEW ZEALAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 209 NEW ZEALAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 210 NEW ZEALAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 211 NEW ZEALAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 212 VIETNAM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 215 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 216 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 218 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 219 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 221 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 222 VIETNAM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 223 VIETNAM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 224 VIETNAM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 225 VIETNAM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 VIETNAM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 227 REST OF ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 ASIA PACIFIC HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC HEART VALVE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC HEART VALVE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC HEART VALVE DEVICES MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC HEART VALVE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC HEART VALVE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC HEART VALVE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA PACIFIC HEART VALVE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC HEART VALVE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 11 GROWING PREVALENCE OF VALVULAR DISEASES, SUCH AS AORTIC STENOSIS & AORTIC REGURGITATION, AND INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES ARE EXPECTED TO DRIVE THE ASIA PACIFIC HEART VALVE DEVICES MARKET IN THE FORECAST PERIOD
FIGURE 12 MECHANICAL HEART VALVE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC HEART VALVE DEVICES MARKET IN 2023 & 2030
FIGURE 13 INCIDENDE AND PREVALENCE OF HEART VALVE OF NORTH AMERICA
FIGURE 14 INCIDENDE AND PREVALENCE OF HEART VALVE OF EUROPE
FIGURE 15 INCIDENDE AND PREVALENCE OF HEART VALVE OF ASIA-PACIFIC
FIGURE 16 INCIDENDE AND PREVALENCE OF HEART VALVE OF SOUTH AMERICA & MIDDLE EAST AND AFRICA
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC HEART VALVE DEVICES MARKET
FIGURE 18 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2022
FIGURE 19 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 20 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 21 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY TREATMENT, 2022
FIGURE 23 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY TREATMENT, 2023-2030 (USD MILLION)
FIGURE 24 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY TREATMENT, CAGR (2023-2030)
FIGURE 25 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY TREATMENT, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY END USER, 2022
FIGURE 27 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA PACIFIC HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY FUNCTIONALITY (2023-2030)
FIGURE 39 ASIA PACIFIC HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
